The Leukemia & Lymphoma Society has announced its first research partnership with a large biopharma company-a four-year, multimillion-dollar deal with Celgene to solicit and fund proposals from academics and smaller biotechs. The not-for-profit organization expects the deal's framework to serve as a template for future collaborations and is in talks with additional big biotech and pharma companies.